Consumer health value sales will continue to grow in 2020, despite the negative economic impact of COVID-19 on the economy. Lower purchasing power among middle-income consumers and the rising cost of healthcare in Argentina have fuelled a shift towards self-medication in recent years, thus encouraging preventive healthcare. Following this...
The outbreak and development of Coronavirus (COVID-19) from early March 2020 halted the economic improvement in the country. Lockdown and other restrictions on business, education and cultural institutions and the population in general fed into rising unemployment, wage cuts and reduced disposable incomes as the government tried to contain...
Acne Vulgaris - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Acne Vulgaris - Pipeline Review, H2 2020, provides an overview of the Acne Vulgaris (Dermatology) pipeline landscape. Acne vulgaris is a chronic skin disease involving blockage...
Consumer health in the UK was positively impacted by the emergence of COVID-19 in Q2 2020 due to notable stockpiling behaviour, a focus on preventive health and consumers adjusting to the new normal. The pandemic and the subsequent lockdown measures introduced by the government in an attempt to halt the spread of the virus resulted in a shift...
Consumer health is expected to record higher retail current value growth in 2020 than in the previous year, returning to the growth rates seen in the middle of the review period. This is due to rising interest in health, brought about by the arrival of the COVID-19 pandemic in the country. The higher growth is despite the challenging economic...
The outbreak of Coronavirus (COVID-19) and the subsequent lockdown have had a strong effect on consumer health in Belgium. Thus, there have been significant switches from category to category, as well as one distribution channel to another due to strong restrictions on retailing. Consumer Health in Belgium report offers a comprehensive...
Acne Medication Market by Therapeutic Class (Retinoids, Antibiotics, Salicylic Acid, Benzoyl Peroxide, and Others), Formulation (Topical Medications and Oral Medications), Type (Prescription Medicines and Over-The-Counter Medicines), Acne Type (Non-Inflammatory Acne and Inflammatory Acne), and Distribution Channel (Retail Stores, Pharmacies...
After seeing strong current value growth for most of the review period, dermatologicals is expected to see a notable slowdown in its growth rate in 2020 due to COVID-19, although the impact varies across categories. Due to restrictions implemented by the government to try and prevent the spread of the virus in the country, consumers have had...
Major players in the acne drugs market are ALLERGAN, Galderma S.A., Valeant Pharmaceutical International Inc., Teva Pharmaceutical Industries Ltd. and Johnson & Johnson Services, Inc. The global acne drugs market is expected to decline from $4.6 billion in 2019 to $3.9 billion in 2020 at a compound annual growth rate (CAGR) of -15%....
Rosacea - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Rosacea - Pipeline Review, H2 2020, provides an overview of the Rosacea (Dermatology) pipeline landscape. Rosacea is a chronic and potentially life-disruptive disorder primarily of the...